Fundraising FoxViewMind Joins Bio-Hermes-002 Landmark Study
1 known investors
Find your way into ViewMind Joins Bio-Hermes-002 Landmark Study
Sign up to find every way you can get introduced to ViewMind Joins Bio-Hermes-002 Landmark Study
- Your email: who you already know at ViewMind Joins Bio-Hermes-002 Landmark Study, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ViewMind Joins Bio-Hermes-002 Landmark Study team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
The Global Alzheimer's Platform Foundation is a nonprofit organization that reduces the time and cost of clinical trials for Alzheimer's and Parkinson's disease by coordinating multi-site research networks and providing trial management, data, and participant recruitment services. It serves pharmaceutical sponsors, contract research organizations, and clinical research sites seeking to accelerate neurodegenerative disease drug development.
Founders & leadership
JD
John DwyerPresident
Investors · 1
Frequently asked questions
- What does ViewMind Joins Bio-Hermes-002 Landmark Study do?
- The Global Alzheimer's Platform Foundation is a nonprofit organization that reduces the time and cost of clinical trials for Alzheimer's and Parkinson's disease by coordinating multi-site research networks and providing trial management, data, and participant recruitment services. It serves pharmaceutical sponsors, contract research organizations, and clinical research sites seeking to accelerate neurodegenerative disease drug development.
- Who are ViewMind Joins Bio-Hermes-002 Landmark Study's investors?
- ViewMind Joins Bio-Hermes-002 Landmark Study's investors include Wealthing VC Club.